Rapid Readout: Angiopoietin-2 (Ang2) Inhibition in the Treatment of Diabetic Macular Edema and Exudative AMD.

EP. 1: Ang-2/VEGF-A Inhibition Synergistic Effect in DME and AMD

Published: March 22nd 2021 | Updated: January 7th 2022

Anat Loewenstein, MD, MHA, explores dual Ang-2/VEGF-A inhibition in the management of diabetic macular edema and exudative age-related macular degeneration.

EP. 2: Angiogenesis 2021 Virtual Symposium Takeaways & Final Thoughts

ByAnat Loewenstein, MD, MHA

Published: March 22nd 2021 | Updated: January 7th 2022

Angiogenesis, Exudation, and Degeneration 2021 Virtual Symposium highlights and thoughts on current treatments options for DME and exudative AMD are discussed.

Rapid Readout: Angiopoietin-2 (Ang2) Inhibition in the Treatment of Diabetic Macular Edema and Exudative AMD.

EP. 1: Ang-2/VEGF-A Inhibition Synergistic Effect in DME and AMD

EP. 2: Angiogenesis 2021 Virtual Symposium Takeaways & Final Thoughts

Trending on Modern Retina

Pegcetacoplan Does Not Impact Anti-VEGF Treatment in Geographic Atrophy, With Ted Leng, MD, MS

EYLEA 8mg in RVO: QUASAR clinical perspectives video

EYLEA 8mg in RVO: snapshot of the 64-week QUASAR data